COMMONWEALTH EQUITY SERVICES, LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 134 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$3,000
-50.0%
19,898
+47.8%
0.00%
Q3 2018$6,0000.0%13,460
+13.5%
0.00%
Q2 2018$6,000
-87.0%
11,860
-40.5%
0.00%
Q1 2018$46,000
-20.7%
19,945
-3.1%
0.00%
Q4 2017$58,00020,5890.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2017
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders